|
|
|
Insider
Information: |
Bozigian Haig P. |
Relationship: |
Chief Development Offi... |
City: |
San Diego |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
1 |
|
Direct
Shares |
157,651 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$21,222,978 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
157,651 |
|
|
Total
Value |
$21,222,978 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Neurocrine Biosciences Inc |
NBIX |
Chief Development Offi... |
2021-02-08 |
157,651 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
92 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 4 of 4
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
NBIX |
Neurocrine Biosciences In... |
Chief Development Officer |
|
2015-01-08 |
4 |
OE |
$2.59 |
$77,700 |
D/D |
30,000 |
88,579 |
0 |
- |
|
NBIX |
Neurocrine Biosciences In... |
Chief Development Officer |
|
2015-01-08 |
4 |
AS |
$27.11 |
$817,200 |
D/D |
(30,000) |
78,579 |
0 |
- |
|
NBIX |
Neurocrine Biosciences In... |
Chief Development Officer |
|
2019-07-15 |
4 |
AS |
$87.50 |
$2,684,506 |
D/D |
(30,680) |
141,976 |
0 |
- |
|
NBIX |
Neurocrine Biosciences In... |
Chief Development Officer |
|
2019-07-15 |
4 |
OE |
$32.99 |
$1,012,133 |
D/D |
30,680 |
172,656 |
0 |
- |
|
NBIX |
Neurocrine Biosciences In... |
Chief Development Officer |
|
2019-05-13 |
4 |
AS |
$75.51 |
$2,608,813 |
D/D |
(34,547) |
141,976 |
0 |
- |
|
NBIX |
Neurocrine Biosciences In... |
Chief Development Officer |
|
2019-05-13 |
4 |
OE |
$8.66 |
$299,177 |
D/D |
34,547 |
176,523 |
0 |
- |
|
NBIX |
Neurocrine Biosciences In... |
Chief Development Officer |
|
2018-11-08 |
4 |
AS |
$110.00 |
$3,992,450 |
D/D |
(36,295) |
135,997 |
0 |
- |
|
NBIX |
Neurocrine Biosciences In... |
Chief Development Officer |
|
2018-11-08 |
4 |
OE |
$8.65 |
$314,147 |
D/D |
36,295 |
152,791 |
0 |
- |
|
NBIX |
Neurocrine Biosciences In... |
Chief Development Officer |
|
2019-07-30 |
4 |
OE |
$32.99 |
$1,725,704 |
D/D |
44,356 |
167,576 |
0 |
- |
|
NBIX |
Neurocrine Biosciences In... |
Chief Development Officer |
|
2019-07-30 |
4 |
AS |
$91.74 |
$4,114,858 |
D/D |
(44,356) |
141,976 |
0 |
- |
|
NBIX |
Neurocrine Biosciences In... |
Chief Development Officer |
|
2017-08-04 |
4 |
OE |
$5.76 |
$317,200 |
D/D |
45,000 |
149,601 |
0 |
- |
|
NBIX |
Neurocrine Biosciences In... |
Chief Development Officer |
|
2020-05-12 |
4 |
OE |
$35.99 |
$3,884,054 |
D/D |
61,555 |
166,690 |
0 |
- |
|
NBIX |
Neurocrine Biosciences In... |
Chief Development Officer |
|
2020-05-12 |
4 |
AS |
$114.94 |
$7,075,396 |
D/D |
(61,555) |
148,633 |
0 |
% |
|
NBIX |
Neurocrine Biosciences In... |
Chief Development Officer |
|
2019-05-16 |
4 |
OE |
$5.76 |
$1,171,789 |
D/D |
66,667 |
142,707 |
0 |
- |
|
NBIX |
Neurocrine Biosciences In... |
Chief Development Officer |
|
2019-05-16 |
4 |
AS |
$80.13 |
$5,341,893 |
D/D |
(66,667) |
141,976 |
0 |
- |
|
NBIX |
Neurocrine Biosciences In... |
Chief Development Officer |
|
2018-03-05 |
4 |
AS |
$90.00 |
$6,828,570 |
D/D |
(75,873) |
135,997 |
0 |
- |
|
NBIX |
Neurocrine Biosciences In... |
Chief Development Officer |
|
2018-03-05 |
4 |
OE |
$5.76 |
$976,703 |
D/D |
75,873 |
150,396 |
0 |
- |
|
92 Records found
|
|
Page 4 of 4 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|